Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues
@article{CCO109751, author = {Ioannis A. Voutsadakis and Antonia Digklia}, title = {Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues}, journal = {Chinese Clinical Oncology}, volume = {12}, number = {1}, year = {2023}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/109751} }